Inventor
Hong Guo
Inventor
Wayland, MA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes36%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
A61FFilters implantable into blood vessels14%
Y10TTechnical subjects covered by former us classification10%
C07KPeptides6%
A01KAnimal husbandry4%
A61BDiagnosis2%
A61MDevices for introducing media into, or onto, the body2%
B82YSpecific uses or applications of nanostructures2%
PatentTitleYear
10,300,114Bioerodible sustained release drug delivery systems20199,962,396Porous silicon drug-eluting particles20189,849,085Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof20179,486,459'Porous silicon drug-eluting particles'20169,192,579'Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof'20159,023,896'Porous silicon drug-eluting particles'20158,871,241'Injectable sustained release delivery devices'20148,815,284'Bioerodible sustained release drug delivery systems'20148,574,659'Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof'20138,574,613'Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof'20138,192,408'Ocular trocar assembly'20128,148,154'Method for preparation of single chain antibodies'20127,998,108'Injector apparatus and method of use'20117,666,424'Methods of preparing and using single chain anti-tumor antibodies'20107,214,710'Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids'20076,765,019'Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids'20046,548,078'Method for treating and/or preventing retinal diseases with sustained release corticosteroids'20036,451,995'Single chain FV polynucleotide or peptide constructs of anti-ganglioside GD2 antibodies, cells expressing same and related methods'20026,375,972'Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof'20026,217,895'Method for treating and/or preventing retinal diseases with sustained release corticosteroids'2001Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2001–2014Based in Belmont, MA, US· patent location history
2002–2012Patents assigned to SLOAN KETTERING INST CANCER (3)· patent assignee history
2002–2012Based in New York, NY, US· patent location history
2002Based in Bellmont, MA, US· patent location history
2011–2019Patents assigned to PSIVIDA INC (12)· patent assignee history
2012–2015Patents assigned to GUO HONG (6)· patent assignee history
2012–2019Based in Wayland, MA, US· patent location history
2013–2015Patents assigned to ASHTON PAUL (5)· patent assignee history
2014–2015Patents assigned to CHEN JIANBING (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PSIVIDA INC | 12 | 2011–2019 |
| GUO HONGself | 6 | 2012–2015 |
| ASHTON PAUL | 5 | 2013–2015 |
| SLOAN KETTERING INST CANCER | 3 | 2002–2012 |
| CHEN JIANBING | 2 | 2014–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Wayland, Massachusetts, US | 9 | 2012–2019 |
| Belmont, Massachusetts, US | 7 | 2001–2014 |
| New York, New York, US | 3 | 2002–2012 |
| Bellmont, Massachusetts, US | 1 | 2002 |